The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biologics Safety Testing-Global Market Insights and Sales Trends 2024
Synopsis
The global Biologics Safety Testing market size is expected to reach US$ 3976.4 million by 2029, growing at a CAGR of 7.0% from 2023 to 2029. The market is mainly driven by the significant applications of Biologics Safety Testing in various end use industries. The expanding demands from the Pharmaceutical and Medical Research, are propelling Biologics Safety Testing market. Endotoxin Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sterility Tests segment is estimated at % CAGR for the next seven-year period.
Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biologics Safety Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biologics Safety Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biologics Safety Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biologics Safety Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biologics Safety Testing covered in this report include Lonza Group, Charles River, Merck, SGS, WuXi AppTec, Thermo Fisher Scientific, Sartorius, Cytovance Biologics and Pace Analytical Services, etc.
The global Biologics Safety Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lonza Group
Charles River
Merck
SGS
WuXi AppTec
Thermo Fisher Scientific
Sartorius
Cytovance Biologics
Pace Analytical Services
Toxikon
Global Biologics Safety Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biologics Safety Testing market, Segment by Type:
Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Cell Line Authentication
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Others
Global Biologics Safety Testing market, by Application
Pharmaceutical
Medical Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biologics Safety Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Biologics Safety Testing market size is expected to reach US$ 3976.4 million by 2029, growing at a CAGR of 7.0% from 2023 to 2029. The market is mainly driven by the significant applications of Biologics Safety Testing in various end use industries. The expanding demands from the Pharmaceutical and Medical Research, are propelling Biologics Safety Testing market. Endotoxin Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sterility Tests segment is estimated at % CAGR for the next seven-year period.
Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biologics Safety Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biologics Safety Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biologics Safety Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biologics Safety Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biologics Safety Testing covered in this report include Lonza Group, Charles River, Merck, SGS, WuXi AppTec, Thermo Fisher Scientific, Sartorius, Cytovance Biologics and Pace Analytical Services, etc.
The global Biologics Safety Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lonza Group
Charles River
Merck
SGS
WuXi AppTec
Thermo Fisher Scientific
Sartorius
Cytovance Biologics
Pace Analytical Services
Toxikon
Global Biologics Safety Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biologics Safety Testing market, Segment by Type:
Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Cell Line Authentication
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Others
Global Biologics Safety Testing market, by Application
Pharmaceutical
Medical Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biologics Safety Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biologics Safety Testing
1.1 Biologics Safety Testing Market Overview
1.1.1 Biologics Safety Testing Product Scope
1.1.2 Biologics Safety Testing Market Status and Outlook
1.2 Global Biologics Safety Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biologics Safety Testing Market Size by Region (2018-2029)
1.4 Global Biologics Safety Testing Historic Market Size by Region (2018-2023)
1.5 Global Biologics Safety Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biologics Safety Testing Market Size (2018-2029)
1.6.1 North America Biologics Safety Testing Market Size (2018-2029)
1.6.2 Europe Biologics Safety Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Biologics Safety Testing Market Size (2018-2029)
1.6.4 Latin America Biologics Safety Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Biologics Safety Testing Market Size (2018-2029)
2 Biologics Safety Testing Market by Type
2.1 Introduction
2.1.1 Endotoxin Tests
2.1.2 Sterility Tests
2.1.3 Cell Line Authentication and Characterization Tests
2.1.4 Bioburden Tests
2.1.5 Cell Line Authentication
2.1.6 Residual Host Contaminant Detection Tests
2.1.7 Adventitious Agent Detection Tests
2.1.8 Others
2.2 Global Biologics Safety Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biologics Safety Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Biologics Safety Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biologics Safety Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biologics Safety Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biologics Safety Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biologics Safety Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biologics Safety Testing Revenue Breakdown by Type (2018-2029)
3 Biologics Safety Testing Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical
3.1.2 Medical Research
3.2 Global Biologics Safety Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biologics Safety Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Biologics Safety Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biologics Safety Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biologics Safety Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biologics Safety Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biologics Safety Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biologics Safety Testing Revenue Breakdown by Application (2018-2029)
4 Biologics Safety Testing Competition Analysis by Players
4.1 Global Biologics Safety Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologics Safety Testing as of 2022)
4.3 Date of Key Players Enter into Biologics Safety Testing Market
4.4 Global Top Players Biologics Safety Testing Headquarters and Area Served
4.5 Key Players Biologics Safety Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Biologics Safety Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Lonza Group
5.1.1 Lonza Group Profile
5.1.2 Lonza Group Main Business
5.1.3 Lonza Group Biologics Safety Testing Products, Services and Solutions
5.1.4 Lonza Group Biologics Safety Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Lonza Group Recent Developments
5.2 Charles River
5.2.1 Charles River Profile
5.2.2 Charles River Main Business
5.2.3 Charles River Biologics Safety Testing Products, Services and Solutions
5.2.4 Charles River Biologics Safety Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Charles River Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Biologics Safety Testing Products, Services and Solutions
5.3.4 Merck Biologics Safety Testing Revenue (US$ Million) & (2018-2023)
5.3.5 SGS Recent Developments
5.4 SGS
5.4.1 SGS Profile
5.4.2 SGS Main Business
5.4.3 SGS Biologics Safety Testing Products, Services and Solutions
5.4.4 SGS Biologics Safety Testing Revenue (US$ Million) & (2018-2023)
5.4.5 SGS Recent Developments
5.5 WuXi AppTec
5.5.1 WuXi AppTec Profile
5.5.2 WuXi AppTec Main Business
5.5.3 WuXi AppTec Biologics Safety Testing Products, Services and Solutions
5.5.4 WuXi AppTec Biologics Safety Testing Revenue (US$ Million) & (2018-2023)
5.5.5 WuXi AppTec Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Biologics Safety Testing Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Biologics Safety Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
5.7 Sartorius
5.7.1 Sartorius Profile
5.7.2 Sartorius Main Business
5.7.3 Sartorius Biologics Safety Testing Products, Services and Solutions
5.7.4 Sartorius Biologics Safety Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Sartorius Recent Developments
5.8 Cytovance Biologics
5.8.1 Cytovance Biologics Profile
5.8.2 Cytovance Biologics Main Business
5.8.3 Cytovance Biologics Biologics Safety Testing Products, Services and Solutions
5.8.4 Cytovance Biologics Biologics Safety Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Cytovance Biologics Recent Developments
5.9 Pace Analytical Services
5.9.1 Pace Analytical Services Profile
5.9.2 Pace Analytical Services Main Business
5.9.3 Pace Analytical Services Biologics Safety Testing Products, Services and Solutions
5.9.4 Pace Analytical Services Biologics Safety Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Pace Analytical Services Recent Developments
5.10 Toxikon
5.10.1 Toxikon Profile
5.10.2 Toxikon Main Business
5.10.3 Toxikon Biologics Safety Testing Products, Services and Solutions
5.10.4 Toxikon Biologics Safety Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Toxikon Recent Developments
6 North America
6.1 North America Biologics Safety Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biologics Safety Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biologics Safety Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biologics Safety Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biologics Safety Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biologics Safety Testing Market Dynamics
11.1 Biologics Safety Testing Industry Trends
11.2 Biologics Safety Testing Market Drivers
11.3 Biologics Safety Testing Market Challenges
11.4 Biologics Safety Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
